Anna Capasso, MD

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Anna Capasso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Aurora Kinases Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

1 Citation (Scopus)

BRAF fusions identified in melanomas have variable treatment responses and phenotypes

Turner, J. A., Bemis, J. G. T., Bagby, S. M., Capasso, A., Yacob, B. W., Chimed, T. S., Van Gulick, R., Lee, H., Tobin, R., Tentler, J. J., Pitts, T., McCarter, M., Robinson, W. A. & Couts, K. L., Feb 21 2019, In : Oncogene. 38, 8, p. 1296-1308 13 p.

Research output: Contribution to journalArticle

RNA Sequence Analysis
4 Citations (Scopus)

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Capasso, A., Lang, J., Pitts, T. M., Jordan, K. R., Lieu, C. H., Davis, S. L., Diamond, J. R., Kopetz, S., Barbee, J., Peterson, J., Freed, B. M., Yacob, B. W., Bagby, S. M., Messersmith, W. A., Slansky, J. E., Pelanda, R. & Eckhardt, S. G., Feb 8 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 37.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Fetal Blood

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

Klauck, P. J., Bagby, S. M., Capasso, A., Bradshaw-Pierce, E. L., Selby, H. M., Spreafico, A., Tentler, J. J., Tan, A. C., Kim, J., Arcaroli, J. J., Purkey, A., Messersmith, W. A., Kuida, K., Eckhardt, S. G. & Pitts, T. M., Feb 5 2018, In : BMC Cancer. 18, 1, 136.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Cell Line
2 Citations (Scopus)

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B. P., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K. D., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

Aurora Kinases
Triple Negative Breast Neoplasms
Phase II Clinical Trials
Angiogenesis Inhibitors
1 Citation (Scopus)

Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived tumor xenograft models via autophagy and signaling mechanisms

Scott, A. J., Arcaroli, J. J., Bagby, S. M., Yahn, R., Huber, K. M., Serkova, N. J., Nguyen, A., Kim, J., Thorburn, A., Vogel, J., Quackenbush, K. S., Capasso, A., Schreiber, A., Blatchford, P., Klauck, P. J., Pitts, T. M., Eckhardt, S. G. & Messersmith, W. A., Oct 1 2018, In : Molecular cancer therapeutics. 17, 10, p. 2112-2122 11 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms